Discrete choice experiments in pharmacy

International Journal of Pharmacy Practice

Volumn 21, Issue 1, 2013, Pages 3-19

  Naik Panvelkar, Pradnya ^a   Armour, Carol ^b   Saini, Bandana ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

discrete choice experiment; methodology; patient preference; pharmacist; pharmacy

Indexed keywords

COMPUTER PROGRAM; CONCEPTUAL FRAMEWORK; CONSENSUS; DISCRETE CHOICE EXPERIMENT; EMBASE; EXPERIMENTAL DESIGN; EXPERIMENTAL STUDY; EXTERNAL VALIDITY; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; INTERNAL VALIDITY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDLINE; OUTCOME ASSESSMENT; PATIENT PREFERENCE; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

CHOICE BEHAVIOR; HUMANS; PATIENT PREFERENCE; PHARMACEUTICAL SERVICES; PHARMACISTS; RESEARCH DESIGN;

EID: 84872236016     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/ijpp.12002     Document Type: Review

References (60)

1. Benavides S, et al. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother 2009; 43: 85-97.
2. Benrimoj SI, Frommer MS,. Community pharmacy in Australia. Aust Health Rev 2004; 28: 238-246.
3. Holland RW, Nimmo CM,. Transitions, part 1: beyond pharmaceutical care. Am J Health Syst Pharm 1999; 156: 1758-1764.
4. Saini B, et al. Role of community pharmacists in asthma-Australian research highlighting pathways for future primary care models. Australas Med J 2011; 4: 190-200.
5. Armour C, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007; 62: 496-502.
6. Morgado MP, et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm 2011; 68: 241-253.
7. Foppe van Mil J, Schulz M,. A review of pharmaceutical care in community pharmacy in Europe. Harvard Health Policy Rev 2006; 7: 155-168.
8. Sinclair HK, et al. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control 1998; 7: 253-261.
9. Sinclair HK, et al. The cost-effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking. Int J Pharm Pract 1999; 7: 107-112.
10. Clifford S, et al. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci 2006; 28: 165-170.
11. Krska J, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30: 205-211.
12. Bernsten C, et al. Pharmaceutical care of the Elderly in Europe Research (PEER) Group. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 2001; 18: 63-77.
13. Bunting BA, Cranor CW,. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc 2006; 46: 133-147.
14. Krass I, et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Med 2007; 24: 677-683.
15. Gordois A, et al. Cost-effectiveness analysis of a pharmacy asthma care program in Australia. Dis Manag Health Out 2007; 15: 387-396.
16. Noyce PR,. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother 2007; 41: 861-868.
17. Blekinsopp A, et al. National Evaluation of the New Community Pharmacy Contract June 2007. London: Pharmacy Practice Research Trust, 2009.
18. Holland R, et al. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Brit J Clin Pharmaco 2008; 65: 303-316.
19. Department of Health. Putting People at the Heart of Care. London: Crown copyright, 2009. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-106038 (accessed 10 November 2011).
20. Horne R, et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007; 7: 8.
21. Phillips KA, et al. A review of studies examining stated preferences for cancer screening. Prev Chronic Dis 2006; 3: A75.
22. Naik Panvelkar P, et al. Measurement of patient satisfaction with community pharmacy services: a review. Pharm World Sci 2009; 31: 525-537.
23. Payne K, Elliott R,. Using discrete choice experiments to value preferences for pharmacy services. Int J Pharm Pract 2005; 13: 9-20.
24. Tinelli M, et al. Discrete choice experiments (DCEs) to inform pharmacy policy: going beyond quality-adjusted life years (QALYs). Int J Pharm Pract 2010; 18 (Suppl. 1): 1.
25. Lancsar E, Louviere J,. Conducting discrete choice experiments to inform healthcare decision making: a user's guide. Pharmacoeconomics 2008; 26: 661-677.
26. Ryan M, et al. Using Discrete Choice Experiments to Value Health and Health Care. New York: Springer, Berlin Heidelberg New York Ed. 2008.
27. Louviere J, Lancsar E,. Choice experiments in health: the good, the bad, the ugly and toward a brighter future. Health Econ Policy Law 2009; 4: 527-546.
28. Viney R, et al. Empirical investigation of experimental design properties of discrete choice experiments in health care. Health Econ 2005; 14: 349-362.
29. Viney R, et al. Discrete choice experiments to measure consumer preferences for health and health care. Expert Rev Pharmacoeconomics Outcomes Res 2002; 2: 319-326.
30. De Bekker-Grob EW, et al. Discrete choice experiments in health economics: a review of the literature. Health Econ 2012; 21: 145-172.
31. Hensher D, et al. Applied Choice Analysis: A Primer. New York: Cambridge University Press, 2005.
32. McIntosh E,. Using discrete choice experiments within a cost-benefit analysis framework: some considerations. Pharmacoeconomics 2006; 24: 855-868.
33. Naik-Panvelkar P, et al. Patients' value of asthma services in Australian pharmacies: the way ahead for asthma care. J Asthma 2012; 49: 310-316.
34. Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
35. Boonen LH, et al. Channeling consumers to preferred providers and the impact of status quo bias: does type of provider matter? Health Serv Res 2011; 46: 510-530.
36. Tinelli M, et al. Patients' preferences for an increased pharmacist role in the management of drug therapy. Int J Pharm Pract 2009; 17: 275-282.
37. Boonen LH, et al. Which preferred providers are really preferred? Effectiveness of insurers' channeling incentives on pharmacy choice. Int J Health Care Finance Econ 2009; 9: 347-366.
38. Halme M, et al. Patients' preferences for generic and branded over-The-counter medicines: an adaptive conjoint analysis approach. Patient 2009; 2: 243-255.
39. Wellman GS, Vidican C,. Pilot study of a hierarchical Bayes method for utility estimation in a choice-based conjoint analysis of prescription benefit plans including medication therapy management services. Res Soc Admin Pharm 2008; 4: 218-230.
40. Porteous T, et al. Preferences for self-care or professional advice for minor illness: a discrete choice experiment. Br J Gen Pract 2006; 56: 911-917.
41. Wang J, et al. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis. Res Soc Admin Pharm 2011; 7: 383-395.
42. Grindrod KA, et al. Pharmacists' preferences for providing patient-centered services: a discrete choice experiment to guide health policy. Ann Pharmacother 2010; 44: 1554-1564.
43. Scott A, et al. Preferences of community pharmacists for extended roles in primary care: a survey and discrete choice experiment. Pharmacoeconomics 2007; 25: 783-792.
44. Ubach C, et al. Using discrete choice experiments to evaluate alternative electronic prescribing systems. Int J Pharm Pract 2002; 10: 191-200.
45. Scalone L, et al. Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study. Haemophilia 2009; 15: 473-486.
46. Mantovani LG, et al. Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experiment. Haemophilia 2005; 11: 589-597.
47. Ryan M,. Using conjoint analysis to go beyond health outcomes and take account of patient preferences: an application to in vitro fertilisation. Soc Sci Med 1999; 48: 535-546.
48. Seston EM, et al. Women's preferences for the provision of emergency hormonal contraception services. Pharm World Sci 2007; 29: 183-189.
49. Wordsworth S, et al. Women's preferences for cervical cancer screening: a study using a discrete choice experiment. Int J Technol Assess 2006; 22: 344-350.
50. King MT, et al. Patient preferences for managing asthma: results from a discrete choice experiment. Health Econ 2007; 16: 703-717.
51. Watson V, et al. Valuing experience factors in the provision of chlamydia screening: an application to women attending the family planning clinic. Value Health 2009; 12: 621-623.
52. Mangham LJ, et al. How to do (or not to do). Designing a discrete choice experiment for application in a low-income country. Health Policy Plann 2009; 24: 151-158.
53. Ryan M, Gerard K,. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2003; 2: 55-64.
54. Eberth B, et al. Does one size fit all? Investigating heterogeneity in men's preferences for benign prostatic hyperplasia treatment using mixed logit analysis. Med Decis Making 2009; 29: 707-715.
55. Hole AR,. Modelling heterogeneity in patients' preferences for the attributes of a general practitioner appointment. J Health Econ 2008; 27: 1078-1094.
56. Mentzakis E, et al. Using discrete choice experiments to value informal care tasks: exploring preference heterogeneity. Health Econ 2011; 20: 930-944.
57. De Bekker-Grob EW, et al. Preferences of GPs and patients for preventive osteoporosis drug treatment: a discrete-choice experiment. Pharmacoeconomics 2009; 27: 211-219.
58. Salkeld G, et al. The veil of experience: do consumers prefer what they know best? Health Econ 2000; 9: 267-270.
59. Naik Panvelkar P, et al. Community pharmacy-based asthma services-what do patients prefer? J Asthma 2010; 47: 1085-1093.
60. Blumenschein K, et al. Hypothetical versus real willingness to pay in the health care sector: results from a field experiment. J Health Econ 2001; 20: 441-457.